Literature DB >> 17290179

Surgery for temporal mediobasal tumors: experience based on a series of 235 patients.

Johannes Schramm1, Ales F Aliashkevich.   

Abstract

OBJECTIVE: To describe the clinical characteristics, diagnosis, various approaches, and outcomes in a retrospective review of a large series of temporomediobasal (TMB) tumors.
METHODS: Charts from 235 patients with TMB tumors were identified from the glioma and epilepsy surgery database and from the electronic operations log. Preoperative magnetic resonance imaging scans were available for all patients and postoperative follow-up was available for 155 of these patients (mean follow-up period, 59 mo; range, 2-172 mo). Preoperative symptoms, approaches, technical problems, and surgical complications are described.
RESULTS: Two hundred and thirty-five patients with intra-axial TMB tumors (mean age, 35 yr) were collected during an 11-year period. The largest tumor groups were astrocytomas (38.0%), gangliogliomas (29.8%), dysembryoplastic neuroepithelial tumor (11.1%), and glioblastomas (11.1%). The most frequent tumor location was the mesial Type A tumor (45.1%), with this type also showing the highest proportion of benign (World Health Organization Grades I and II) histological features (91.3%). Of all tumors, 76.2% were benign. Larger tumor size was associated with higher frequency of malignant histopathological findings. The leading symptom was epilepsy in 91% of patients, followed by drug-resistant epilepsy in 71.5%. Significant preoperative neurological deficits, such as hemiparesis or aphasia, were seen in 3.8% of the patients; another 12% had visual field deficits. Thirty-eight patients with low-grade tumors had undergone surgery previously. Several surgical approaches were chosen: transsylvian in 28%, anterior two-thirds temporal lobe resection in 23%, temporal pole resection in 15.3%, subtemporal in 19%, and transcortical in 6%. The most frequent neurological complications were transient: dysphasia (4.2%), hemiparesis (5%), and oculomotor disturbance (2.5%). Permanent nonvisual neurological complications occurred in fewer than 2% of the patients and significant new hemianopic defects were found in another 5.4% of the patients. The most severe complication was one intraoperative internal carotid artery lesion. One patient died.
CONCLUSION: Small tumor size, magnetic resonance imaging, and microsurgery have made resection of mostly benign TMB tumors possible in a large number of patients. This series supports the conclusion that these tumors can be operated on with a relative degree of safety for the patient, provided that the anatomy of the mesial temporal lobe and the variety of approaches are well known to the surgeon. However, because of the complex anatomic structures in the vicinity, transient neurological deterioration is not infrequent and certain neurological disturbances (e.g., quadrantanopia) even seem to be unavoidable, whereas permanent significant deficits are rare.

Entities:  

Mesh:

Year:  2007        PMID: 17290179     DOI: 10.1227/01.NEU.0000249281.69384.D7

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  Transsylvian-transinsular approaches to the insula and basal ganglia: operative techniques and results with vascular lesions.

Authors:  Matthew B Potts; Edward F Chang; William L Young; Michael T Lawton
Journal:  Neurosurgery       Date:  2012-04       Impact factor: 4.654

Review 2.  Epilepsy associated tumors: Review article.

Authors:  Marco Giulioni; Gianluca Marucci; Matteo Martinoni; Anna Federica Marliani; Francesco Toni; Fiorina Bartiromo; Lilia Volpi; Patrizia Riguzzi; Francesca Bisulli; Ilaria Naldi; Roberto Michelucci; Agostino Baruzzi; Paolo Tinuper; Guido Rubboli
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

Review 3.  [Recommendations for a standardized perimetry within the framework of epilepsy surgery].

Authors:  M T Lutz; T Mayer; U Schiefer
Journal:  Ophthalmologe       Date:  2011-07       Impact factor: 1.059

4.  Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.

Authors:  Melissa Kerkhof; Janneke C M Dielemans; Melanie S van Breemen; Hanneke Zwinkels; Robert Walchenbach; Martin J Taphoorn; Charles J Vecht
Journal:  Neuro Oncol       Date:  2013-05-16       Impact factor: 12.300

Review 5.  The transsylvian approach for resection of insular gliomas: technical nuances of splitting the Sylvian fissure.

Authors:  Michael M Safaee; Dario J Englot; Seunggu J Han; Michael T Lawton; Mitchel S Berger
Journal:  J Neurooncol       Date:  2016-06-13       Impact factor: 4.130

6.  Patterns of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as an Invasion-Spared Brain Region.

Authors:  Awais A Mughal; Lili Zhang; Artem Fayzullin; Andres Server; Yuping Li; Yingxi Wu; Rainer Glass; Torstein Meling; Iver A Langmoen; Trygve B Leergaard; Einar O Vik-Mo
Journal:  Neoplasia       Date:  2018-05-21       Impact factor: 5.715

7.  Vascularization of the uncus - Anatomical study and clinical implications.

Authors:  Gustavo Rassier Isolan; Antônio Carlos Huf Marrone; Luiz Carlos Porcellos Marrone; Marco Antonio Stefani; Jaderson Costa da Costa; Joao Paulo Mota Telles; Gil Goulart Choi; Saul Almeida da Silva; Nícollas Nunes Rabelo; Eberval Gadelha Figueiredo
Journal:  Surg Neurol Int       Date:  2021-08-09

Review 8.  Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives.

Authors:  Fidan Seker-Polat; Nareg Pinarbasi Degirmenci; Ihsan Solaroglu; Tugba Bagci-Onder
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.